Skip to content

ELECTROMEDICAL TECHNOLOGIES, INC.: 10-Q filed 2023-11-20

What ELECTROMEDICAL TECHNOLOGIES, INC. reported in its quarterly report filed 2023-11-20 (fiscal Q3 2023): 45 published measures, 127 facts as tagged in accession 0001410578-23-002548.

This filing

Form
10-Q (quarterly report)
Filed
2023-11-20
Fiscal period
fiscal Q3 2023
Accession
0001410578-23-002548 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ELECTROMEDICAL TECHNOLOGIES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2023-09-30853,403USD
At 2022-12-311,353,271USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2023-09-303,369,327USD
At 2022-12-313,574,116USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2023-09-30-2,515,924USD
At 2023-06-30-2,282,023USD
At 2023-03-31-1,032,908USD
At 2022-12-31-2,220,845USD
At 2022-09-30-1,735,758USD
At 2022-06-30-1,313,790USD
At 2022-03-31-1,699,029USD
At 2021-12-31-722,503USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2023-09-30138,477USD
At 2022-12-31368,425USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-376,720USD92
2023-01-01 to 2023-09-30-2,292,589USD273
2023-04-01 to 2023-06-30-1,459,806USD91
2023-01-01 to 2023-03-31-456,063USD90
2022-07-01 to 2022-09-30-957,946USD92
2022-01-01 to 2022-09-30-2,638,413USD273
2022-04-01 to 2022-06-30-535,931USD91
2022-01-01 to 2022-03-31-1,144,536USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-01-01 to 2023-09-30-1,366,445USD273
2022-01-01 to 2022-09-30-740,238USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2023-01-01 to 2023-09-30149,705USD273

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2023-07-01 to 2023-09-30323,613USD92
2023-01-01 to 2023-09-30997,213USD273
2022-07-01 to 2022-09-30279,551USD92
2022-01-01 to 2022-09-30726,696USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2023-01-01 to 2023-09-30-608,386USD273
2022-01-01 to 2022-09-30815,983USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2023-01-01 to 2023-09-301,744,883USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2023-09-30-27,121,091USD
At 2022-12-31-24,825,041USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2023-07-01 to 2023-09-30466,219,492shares92
2023-01-01 to 2023-09-30348,089,518shares273
2022-07-01 to 2022-09-30146,993,139shares92
2022-01-01 to 2022-09-30119,799,025shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2023-07-01 to 2023-09-30466,219,492shares92
2023-01-01 to 2023-09-30348,089,518shares273
2022-07-01 to 2022-09-30146,993,139shares92
2022-01-01 to 2022-09-30119,799,025shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2023-07-01 to 2023-09-300USD/shares92
2023-01-01 to 2023-09-30-0.01USD/shares273
2022-07-01 to 2022-09-30-0.01USD/shares92
2022-01-01 to 2022-09-30-0.02USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2023-07-01 to 2023-09-300USD/shares92
2023-01-01 to 2023-09-30-0.01USD/shares273
2022-07-01 to 2022-09-30-0.01USD/shares92
2022-01-01 to 2022-09-30-0.02USD/shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2023-09-30149,705USD
At 2022-12-31705,469USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2023-01-01 to 2023-09-30715,000USD273
2022-01-01 to 2022-09-30484,603USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-239,029USD92
2023-01-01 to 2023-09-30-1,841,970USD273
2022-07-01 to 2022-09-30-337,376USD92
2022-01-01 to 2022-09-30-1,346,196USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2023-09-30543,004USD
At 2022-12-31647,802USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2023-07-01 to 2023-09-30162,121USD92
2023-01-01 to 2023-09-30834,809USD273
2022-07-01 to 2022-09-30160,570USD92
2022-01-01 to 2022-09-30510,417USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2023-09-303,090,835USD
At 2022-12-312,924,175USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2023-09-30277,714USD
At 2022-12-31266,744USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2023-09-309,200USD
At 2022-12-319,444USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2023-09-30131,310USD
At 2022-12-3162,061USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2023-07-01 to 2023-09-30251,176USD92
2023-01-01 to 2023-09-30774,561USD273
2022-07-01 to 2022-09-30221,543USD92
2022-01-01 to 2022-09-30555,712USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2023-07-01 to 2023-09-3072,437USD92
2023-01-01 to 2023-09-30222,652USD273
2022-07-01 to 2022-09-3058,008USD92
2022-01-01 to 2022-09-30170,984USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2023-07-01 to 2023-09-30490,205USD92
2023-01-01 to 2023-09-302,616,531USD273
2022-07-01 to 2022-09-30558,919USD92
2022-01-01 to 2022-09-301,901,908USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2023-09-30471,495,856shares
At 2022-12-31189,784,529shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2023-09-30138,477USD
At 2022-12-31368,425USD
At 2022-09-30458,915USD
At 2021-12-31383,170USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2023-09-3023,835,454USD
At 2022-12-3122,237,300USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2023-09-30160,694USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2023-09-30174,692USD
At 2022-12-31899,987USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2023-09-3024,987USD
At 2022-12-31194,518USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2023-09-309,174USD
At 2022-12-3110,234USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2023-09-30264,017USD
At 2022-12-31207,872USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2023-09-30130,100USD
At 2022-12-31217,588USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2023-01-01 to 2023-09-30-2,292,589USD273
2022-01-01 to 2022-09-30-2,638,413USD273

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-376,720USD92
2023-01-01 to 2023-09-30-2,296,050USD273
2022-07-01 to 2022-09-30-977,726USD92
2022-01-01 to 2022-09-30-2,721,574USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2023-07-01 to 2023-09-300USD92
2023-01-01 to 2023-09-304,557USD273
2022-07-01 to 2022-09-305,469USD92
2022-01-01 to 2022-09-3016,406USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-137,691USD92
2023-01-01 to 2023-09-30-450,619USD273
2022-07-01 to 2022-09-30-620,570USD92
2022-01-01 to 2022-09-30-1,292,217USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2023-01-01 to 2023-09-3036,901USD273
2022-01-01 to 2022-09-3089,079USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2023-02-01 to 2023-02-2812,000USD28
2022-01-01 to 2022-09-3042,766USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-09-30-244USD273
2022-01-01 to 2022-09-30-18,404USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-09-3069,249USD273
2022-01-01 to 2022-09-30-100,960USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-09-3010,970USD273
2022-01-01 to 2022-09-3062,300USD273

Inspect the source

Entity
ELECTROMEDICAL TECHNOLOGIES, INC. / CIK 0001715819
Captured
2026-09-21T17:24:36.315Z
SEC response SHA-256
2ad8df4a9c5fb16e050ace525a2934e53474d15f46925e8496da9b3607574d0f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001715819.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))